Market Closed - Nasdaq Stockholm 11:15:35 2024-05-03 am EDT 5-day change 1st Jan Change
0.94 SEK -5.24% Intraday chart for NEOS AB +2.84% -57.27%

Business Summary

NeoDynamics AB (publ) is a Sweden-based company engaged in the medical industry. The Company focuses on developing and commercializing products for breast cancer screening, imaging, and breast cancer treatments. The Company’s product NeoNavia, enables a pulse biopsy system for ultrasound guided tissue sampling. It consists of a base unit, a handheld driver and three different types of biopsy needles. Each needle type is driven by the pulse technology providing a more controlled needle insertion and precise placement of the needle in the tumour whilst enabling tissue samples from both breasts and lymph nodes. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. NeoNavia is evaluated for breast cancer diagnosis at clinics in United Kingdom, Germany, and Sweden.

Number of employees: 9

Sales per Business

SEK in Million2021Weight2022Weight Delta
Diagnosis & Treatment of Breast Cancer
100.0 %
1 100.0 % 0 100.0 % -88.39%

Sales per region

SEK in Million2021Weight2022Weight Delta
Sweden
100.0 %
1 100.0 % 0 100.0 % -88.39%

Managers

Managers TitleAgeSince
Director of Finance/CFO - 22-01-31
Chief Tech/Sci/R&D Officer - 09-01-31
Chief Operating Officer - 12-04-30
Sales & Marketing - 22-11-07
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 63 17-12-31
Director/Board Member 71 14-12-31
Director/Board Member - 20-12-31
Chairman 56 15-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 32,606,779 303,010 ( 0.9293 %) 0 0.9293 %

Company contact information

NeoDynamics AB

Lejonvägen 14

181 32, Lidingö

+46 8 52 27 96 67

http://www.neodynamics.se
address NEOS AB(NEOD)